Recro Pharma Inc. (REPH)
NASDAQ: REPH
· Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM
Recro Pharma Revenue
Recro Pharma reported an annual revenue of $94.64M, reflecting a 4.9% growth. For the quarter ending December 31, 2023, Recro Pharma generated $27.72M in revenue.
Revenue (ttm)
94.64M
Revenue Growth
4.9%
Price / Sales Ratio
2.1
Revenue / Employee
511.54K
Employees
185
Market Cap
177.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 94.64M | +4.90% |
| Dec 31, 2022 | 90.21M | +19.71% |
| Dec 31, 2021 | 75.36M | +13.33% |
| Dec 31, 2020 | 66.5M | -32.98% |
| Dec 31, 2019 | 99.22M | +28.28% |
| Dec 31, 2018 | 77.35M | +7.67% |
| Dec 31, 2017 | 71.83M | +3.60% |
| Dec 31, 2016 | 69.34M | +33.46% |
| Dec 31, 2015 | 51.95M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Dec 31, 2011 | 0 | n/a |